As part of AbbVie’s commitment to recognising and managing Complex/Advanced Parkinson’s disease, we have developed a series of downloadable resources for healthcare professionals. These provide guidance on the role device-aided therapy plays in the management of Parkinson’s disease and where it fits in the patient treatment pathway.
Additional insights on the management of Complex/Advanced Parkinson's disease can be found in the on-demand AbbVie promotional sponsored symposium from the Parkinson's Academy webinar in May 2021.
Downloadable materials for HCPs
Parkinson’s Academy on-demand webinar
An AbbVie promotional sponsored symposium from the Parkinson's Academy webinar May 2021, where the speakers discussed the following topics.
- Jenny Wright: Complex/Advanced Parkinson’s: Understanding the scale of the problem.
- Prof Nicola Pavese: Patient triage: Ensuring the timely recognition and referral for advanced therapy.
- Dr Pamela Seenan: Choosing the right advanced therapy: Key considerations for device-aided therapy.
References
- DUODOPA (levodopa/carbidopa intestinal gel) Summary of Product Characteristics. Available at: https://www.medicines.org.uk/emc/medicine/20786. Accessed August 2022.
Adverse events should be reported. Reporting forms and information can be found at yellowcard.mhra.gov.uk.
Adverse events should also be reported to AbbVie on [email protected]
UK-DUOD-210224. Date of preparation: August 2022.